241 related articles for article (PubMed ID: 31475807)
1. Antibiotic selection in the treatment of acute invasive infections by Pseudomonas aeruginosa.
Cardozo C; Rico V; Agüero D; Soriano A
Rev Esp Quimioter; 2019 Sep; 32 Suppl 2(Suppl 2):32-34. PubMed ID: 31475807
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic selection in the treatment of acute invasive infections by Pseudomonas aeruginosa: Guidelines by the Spanish Society of Chemotherapy.
Mensa J; Barberán J; Soriano A; Llinares P; Marco F; Cantón R; Bou G; González Del Castillo J; Maseda E; Azanza JR; Pasquau J; García-Vidal C; Reguera JM; Sousa D; Gómez J; Montejo M; Borges M; Torres A; Alvarez-Lerma F; Salavert M; Zaragoza R; Oliver A
Rev Esp Quimioter; 2018 Feb; 31(1):78-100. PubMed ID: 29480677
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of antibiotic resistance in Pseudomonas aeruginosa. Implications for empiric and definitive therapy.
Ruiz-Garbajosa P; Cantón R
Rev Esp Quimioter; 2017 Sep; 30 Suppl 1():8-12. PubMed ID: 28882007
[TBL] [Abstract][Full Text] [Related]
4. Multicentre surveillance of Pseudomonas aeruginosa susceptibility patterns in nosocomial infections.
Van Eldere J
J Antimicrob Chemother; 2003 Feb; 51(2):347-52. PubMed ID: 12562701
[TBL] [Abstract][Full Text] [Related]
5. Previous Antibiotic Exposure and Antimicrobial Resistance Patterns of
Djordjevic ZM; Folic MM; Jankovic SM
Balkan Med J; 2017 Dec; 34(6):527-533. PubMed ID: 29215335
[TBL] [Abstract][Full Text] [Related]
6. Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved?
Bhat S; Fujitani S; Potoski BA; Capitano B; Linden PK; Shutt K; Paterson DL
Int J Antimicrob Agents; 2007 Nov; 30(5):458-62. PubMed ID: 17703923
[TBL] [Abstract][Full Text] [Related]
7. In vitro interaction of various antibiotic combinations recommended by Chinese consensus statement against carbapenems-resistant Pseudomonas aeruginosa.
Ma W; Li J; Wang D; Yu C; Sun S
Lett Appl Microbiol; 2019 Sep; 69(3):198-203. PubMed ID: 31236975
[TBL] [Abstract][Full Text] [Related]
8. [In-vitro antibiotic resistance of hospital and non-hospital strains of Pseudomonas aeruginosa].
Ceddia T; Marinucci MC; Parravano N
Boll Soc Ital Biol Sper; 1979 Mar; 55(6):529-33. PubMed ID: 121701
[TBL] [Abstract][Full Text] [Related]
9. Pseudomonas aeruginosa is not just in the intensive care unit any more: implications for empirical therapy.
Eagye KJ; Banevicius MA; Nicolau DP
Crit Care Med; 2012 Apr; 40(4):1329-32. PubMed ID: 22425824
[TBL] [Abstract][Full Text] [Related]
10. Contribution of clonal dissemination and selection of mutants during therapy to Pseudomonas aeruginosa antimicrobial resistance in an intensive care unit setting.
Juan C; Gutiérrez O; Oliver A; Ayestarán JI; Borrell N; Pérez JL
Clin Microbiol Infect; 2005 Nov; 11(11):887-92. PubMed ID: 16216103
[TBL] [Abstract][Full Text] [Related]
11. Pathogen burden & associated antibiogram of
Kumari M; Khurana S; Bhardwaj N; Malhotra R; Mathur P
Indian J Med Res; 2019 Feb; 149(2):295-298. PubMed ID: 31219098
[TBL] [Abstract][Full Text] [Related]
12. Should we be afraid of the Green Monster?
Rumbaugh K
Crit Care Med; 2009 May; 37(5):1826-7. PubMed ID: 19373066
[No Abstract] [Full Text] [Related]
13. Current therapies for pseudomonas aeruginosa.
Giamarellou H; Kanellakopoulou K
Crit Care Clin; 2008 Apr; 24(2):261-78, viii. PubMed ID: 18361945
[TBL] [Abstract][Full Text] [Related]
14. Pseudomonas aeruginosa susceptibility in a university hospital: recognition and treatment.
Rotschafer JC; Shikuma LR
Drug Intell Clin Pharm; 1986; 20(7-8):575-81. PubMed ID: 3091346
[TBL] [Abstract][Full Text] [Related]
15. [In vitro sensitivity of 39 strains of Pseudomonas aeruginosa isolated from urine culture of hospitalized patients].
Vanni M; Zucca C
Minerva Med; 1986 Jun; 77(27):1289-92. PubMed ID: 3088493
[TBL] [Abstract][Full Text] [Related]
16. In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy.
Riou M; Carbonnelle S; Avrain L; Mesaros N; Pirnay JP; Bilocq F; De Vos D; Simon A; Piérard D; Jacobs F; Dediste A; Tulkens PM; Van Bambeke F; Glupczynski Y
Int J Antimicrob Agents; 2010 Dec; 36(6):513-22. PubMed ID: 20926262
[TBL] [Abstract][Full Text] [Related]
17. [Hospital infections caused by Pseudomonas aeruginosa. Significance in intensive therapy].
Sidorenko SV; Gel'fand EB; Mamontova OA
Anesteziol Reanimatol; 1999; (3):46-54. PubMed ID: 10458038
[TBL] [Abstract][Full Text] [Related]
18. Pseudomonas aeruginosa: Evaluation of Pathogen Burden and Drug-Resistance Trends in a Tertiary Care Hospital.
Saeed M; Rasheed F; Afzal RK; Hussain S; Riaz S; Ahmad A
J Coll Physicians Surg Pak; 2018 Apr; 28(4):279-283. PubMed ID: 29615167
[TBL] [Abstract][Full Text] [Related]
19. [Molecular epidemiology of beta-lactamases in ceftazidime-resistant Pseudomonas aeruginosa isolates].
Er H; Altındiş M; Aşık G; Demir C
Mikrobiyol Bul; 2015 Apr; 49(2):156-65. PubMed ID: 26167816
[TBL] [Abstract][Full Text] [Related]
20. Comparison of antibiotic susceptibility patterns in Pseudomonas aeruginosa isolated from adult patients with cystic fibrosis (CF) with invasive Pseudomonas aeruginosa from non-CF patients.
Rao P; McCaughan J; McCalmont M; Goldsmith CE; Hall V; Millar BC; McCann MA; Downey DG; Rendall JC; Elborn JS; Moore JE
J Cyst Fibros; 2012 Jul; 11(4):349-52. PubMed ID: 22325689
[No Abstract] [Full Text] [Related]
[Next] [New Search]
